Delivery Order SPE2DB20D3103-SPE2DB25FP7A3
- Not listed
- The Defense Logistics Agency awarded a $6,788.95 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,390.30 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This competitive award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $9,922.90 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment of medical supply needs through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,188.74. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,405.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors valued at $1,031.20 under a firm fixed price contract. This non-set-aside award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.44 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7A3Delivery Order
The Defense Logistics Agency awarded a $7,232.56 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract with an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical devices to support military healthcare programs worldwide. The Dexcom G7 sensor delivery order reflects the company's role as a critical vendor for federal medical procurement, serving Defense Health Agency and other government healthcare systems with diabetes management and monitoring devices as part of the company's extensive portfolio of medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 7/31/25 |